Two Labs is an industry leader in all facets of pharma services. Our professional, experienced team offers a wealth of skills and knowledge to manage the complexities of pharma product commercialization, market access and market intelligence.
The cost of treating cancer patients is high and rising in the United States. Payers are exposed to cost through doctor visits, laboratory tests, imaging tests, radiation treatment, drugs, hospital stays, surgery, home care, transportation and travel, and caregiving.
With the recent patent expiry of Humira® (adalimumab) in Europe, NHS England last week published a press release reiterating their goal of realizing £300 million in annual savings through the adoption of best value biologic medicines (originator or biosimilar) by 2021.
Industry-leading pharmaceutical services company, Two Labs, today announced it has acquired Pennside Partners Ltd., an international provider of market insights, benchmarking and competitive intelligence services for the pharmaceutical, biotech, and medical device sectors.
Two Labs, an industry-leading pharma and life science services company, announced at Asembia’s 2018 Specialty Pharmacy Summit that Anita Dopkosky, a pharmaceutical industry executive, has joined the Commercialization team as Vice President of Specialty Pharmacy.
Two Labs, an industry-leading pharma and life science services company, today announced that it has acquired MKO Global Partners (MKO), a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets.